- TheImmuneSelectionofHER2~+andHER2~-TumorCellsbyHSP65-HER2;HER2HeterogeneityAffectsTrastuzumabResponsesandSurvivalinPatientsWithHER2-PositiveMetastaticBreastCancer.ExperimentalStudiesonHighlySpecificHER2/neuChiralPeptideVaccine;StudyofHER2GeneSilencingb...
- 13215